In specific, patients susceptible to chronic anemia, including cancer patients undergoing chemotherapy, may utilize this device to monitor their [Hb] at convenience and transmit the results to primary care physicians if their [Hb] levels vary abnormally from the normal baseline. The gene discussed is GSTM1; the disease is cancer.